Search

everythinglearnresearchcommunity

for

Search:↓

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

NonClassic Congenital Adrenal Hyperplasia is a less severe form of a genetic disorder affecting adrenal gland function.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Herbal treatments can help with early-stage BPH symptoms, but more research is needed.

Men with enlarged prostates often have more severe baldness.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

High doses of finasteride cause cell growth and tumors in mice.

SLHA can be hard to diagnose and needs teamwork between specialists.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Early hair loss may indicate prostate issues.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Ganoderma lucidum may help treat enlarged prostate in rats.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.